Dealroom maps LumiraDx's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock LumiraDx's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$45M patent portfolio · 37 active families

Estimated portfolio value

$45M

11.7% of market cap · 5.5× smaller than top peer CMR Surgical ($243M)

37 active patent families

Where LumiraDx innovates ChemistryMolecular biologyAir liquid interfaceAnti immunoglobulinsAssay

Where LumiraDx concentrates vs peers

Each axis is a top-10 topic across LumiraDx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about LumiraDx

An AI-synthesized read of the highest-engagement posts about LumiraDx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LumiraDx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles